Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Pfizer, Zhejiang Hisun sign JV to develop, manufacture, and sell branded generics; Pfizer sells off stake

Executive Summary

Pfizer Inc. and Chinese pharmaco Zhejiang Hisun Pharmaceutical Co. Ltd. seek to create the joint venture named Hisun-Pfizer Pharmaceuticals Co. Ltd., which will develop, manufacture, and commercialize off-patent pharmaceutical products in China and other markets worldwide. The partners signed a memorandum of understanding in June 2011.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Joint Venture
    • Includes Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register